GILEAD SCIENCES, INC. — Director's Dealing 2016

May 4, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2016-05-02

Reporting Person: Carter Paul Rutherford (EVP Commercial Ops)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-05-02	Common Stock	M	1817	$40.56	Acquired	62939	Direct
2016-05-02	Common Stock	M	183	$24.905	Acquired	63122	Direct
2016-05-02	Common Stock	S	2000	$88.7239	Disposed	61122	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-02	Non-qualified Stock Option (Right to Buy)	$40.56	M	1817	Disposed	2023-02-01	Common Stock (1817)	Direct
2016-05-02	Non-qualified Stock Option (Right to Buy)	$24.905	M	183	Disposed	2019-07-29	Common Stock (183)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.

F3: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.

F4: Sale prices reported for the transactions reported here range from $88.715 to $88.765. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.